AC
ADAR1 Capital Management, LLC
AUSTIN TX · SEC CIK 0001940272
$2.19B2026Q2 reported value
277Positions
40.8%Top 10 weight · largest 11.0%
35 / 77New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
ABVX Added+$54.73M
AGIO Added+$42.58M
SPY Added+$39.69M
ZLAB Added+$36.93M
EDIT New+$28.80M
2026Q2 top sells estimated at quarter-end value
TERNS PHARMACEUT Sold out-$48.22M
BEAM Sold out-$34.47M
DNLI Reduced-$21.67M
SRRK Sold out-$20.02M
CYTK Reduced-$14.88M
2026Q2 holdings click a header to sort · 100 rows per page
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | $240.49M | 11.01% | 1,804,703 | 410,684 | 29.5% | $54.73M | Added |
| PTGX | PROTAGONIST THERAPEUTICS INC | $117.78M | 5.39% | 960,863 | -33,256 | -3.3% | -$4.08M | Reduced |
| ROIV | ROIVANT SCIENCES LTD | $111.73M | 5.11% | 3,157,008 | -128,898 | -3.9% | -$4.56M | Reduced |
| SPY | STATE STR SPDR S&P 500 ETF T | $96.40M | 4.41% | 129,087 | 53,147 | 70.0% | $39.69M | Added |
| IMVT | IMMUNOVANT INC | $89.80M | 4.11% | 2,330,716 | -348,294 | -13.0% | -$13.42M | Reduced |
| ZLAB | ZAI LAB LTD | $64.01M | 2.93% | 3,369,034 | 1,943,667 | 136.4% | $36.93M | Added |
| AGIO | AGIOS PHARMACEUTICALS INC | $47.80M | 2.19% | 1,288,053 | 1,147,381 | 815.6% | $42.58M | Added |
| — | CRINETICS PHARMACEUTICALS IN | $45.73M | 2.09% | 1,222,080 | 82,749 | 7.3% | $3.10M | Added |
| BOXX | EA SERIES TRUST | $39.47M | 1.81% | 337,125 | 0 | 0.0% | — | Unchanged |
| CYTK | CYTOKINETICS INC | $39.01M | 1.79% | 457,907 | -174,649 | -27.6% | -$14.88M | Reduced |
| SEPN | SEPTERNA INC | $31.51M | 1.44% | 940,747 | -149,071 | -13.7% | -$4.99M | Reduced |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | $30.98M | 1.42% | 3,145,096 | -644,036 | -17.0% | -$6.34M | Reduced |
| EDIT | EDITAS MEDICINE INC | $28.80M | 1.32% | 8,889,000 | 8,889,000 | — | $28.80M | New |
| DNLI | DENALI THERAPEUTICS INC | $26.47M | 1.21% | 1,029,080 | -842,375 | -45.0% | -$21.67M | Reduced |
| SYRE | SPYRE THERAPEUTICS INC | $25.21M | 1.15% | 283,982 | -54,341 | -16.1% | -$4.82M | Reduced |
| VIR | VIR BIOTECHNOLOGY INC | $25.03M | 1.15% | 2,456,677 | -288,037 | -10.5% | -$2.94M | Reduced |
| PRAX | PRAXIS PRECISION MEDICINES I | $24.86M | 1.14% | 74,253 | 72,753 | 4,850.2% | $24.36M | Added |
| INSM | INSMED INC | $24.36M | 1.12% | 228,520 | 193,128 | 545.7% | $20.59M | Added |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $23.05M | 1.05% | 619,542 | 191,726 | 44.8% | $7.13M | Added |
| VKTX | VIKING THERAPEUTICS INC | $22.39M | 1.02% | 574,038 | 346,321 | 152.1% | $13.51M | Added |
| TSHA | TAYSHA GENE THERAPIES INC | $20.71M | 0.95% | 3,040,466 | 61,037 | 2.0% | $415,662 | Added |
| MNPR | MONOPAR THERAPEUTICS INC | $20.15M | 0.92% | 217,595 | -46,683 | -17.7% | -$4.32M | Reduced |
| OVID | OVID THERAPEUTICS INC | $19.95M | 0.91% | 7,417,479 | 2,873,366 | 63.2% | $7.73M | Added |
| ELVN | ENLIVEN THERAPEUTICS INC | $19.68M | 0.90% | 387,718 | 58,178 | 17.7% | $2.95M | Added |
| ENTA | ENANTA PHARMACEUTICALS INC | $19.60M | 0.90% | 1,344,510 | 1,293,153 | 2,518.0% | $18.85M | Added |
| IWM | ISHARES TR Put | $18.78M | 0.86% | 62,500 | 35,000 | 127.3% | $10.52M | Added |
| SPY | STATE STR SPDR S&P 500 ETF T Put | $18.67M | 0.85% | 25,000 | 25,000 | — | $18.67M | New |
| NKTR | NEKTAR THERAPEUTICS | $17.05M | 0.78% | 244,184 | 82,932 | 51.4% | $5.79M | Added |
| INSP | INSPIRE MED SYS INC | $16.71M | 0.76% | 374,617 | -30,580 | -7.5% | -$1.36M | Reduced |
| RVMD | REVOLUTION MEDICINES INC | $16.39M | 0.75% | 87,509 | -46,384 | -34.6% | -$8.69M | Reduced |
| ESTA | ESTABLISHMENT LABS HLDGS INC | $15.93M | 0.73% | 185,619 | -27,854 | -13.0% | -$2.39M | Reduced |
| PRTA | PROTHENA CORP PLC | $15.22M | 0.70% | 1,554,535 | -26,908 | -1.7% | -$263,429 | Reduced |
| RYTM | RHYTHM PHARMACEUTICALS INC | $15.12M | 0.69% | 136,158 | -75,292 | -35.6% | -$8.36M | Reduced |
| IKT | INHIBIKASE THERAPEUTICS INC | $15.00M | 0.69% | 7,387,205 | 780,633 | 11.8% | $1.58M | Added |
| QURE | UNIQURE NV | $14.95M | 0.68% | 324,672 | 248,466 | 326.0% | $11.44M | Added |
| RLYB | RALLYBIO CORP | $14.82M | 0.68% | 926,352 | 905,817 | 4,411.1% | $14.49M | Added |
| REGN | REGENERON PHARMACEUTICALS | $13.85M | 0.63% | 22,208 | 10,054 | 82.7% | $6.27M | Added |
| IVA | INVENTIVA SA | $13.63M | 0.62% | 3,606,656 | 1,432,258 | 65.9% | $5.41M | Added |
| STRO | SUTRO BIOPHARMA INC | $13.41M | 0.61% | 404,014 | -120,427 | -23.0% | -$4.00M | Reduced |
| IONS | IONIS PHARMACEUTICALS INC | $13.18M | 0.60% | 166,286 | 5,948 | 3.7% | $471,617 | Added |
| BBIO | BRIDGEBIO PHARMA INC | $13.16M | 0.60% | 176,689 | 82,397 | 87.4% | $6.14M | Added |
| SRPT | SAREPTA THERAPEUTICS INC | $13.13M | 0.60% | 730,649 | 468,591 | 178.8% | $8.42M | Added |
| CTMX | CYTOMX THERAPEUTICS INC. | $12.62M | 0.58% | 3,365,118 | -45,072 | -1.3% | -$169,020 | Reduced |
| VOR | VOR BIOPHARMA INC | $12.53M | 0.57% | 680,626 | 680,626 | — | $12.53M | New |
| BIL | SPDR SERIES TRUST | $12.43M | 0.57% | 135,585 | 0 | 0.0% | — | Unchanged |
| EQ | EQUILLIUM INC | $12.03M | 0.55% | 3,758,569 | 31,910 | 0.9% | $102,112 | Added |
| ANL | ADLAI NORTYE LTD | $11.70M | 0.54% | 1,017,805 | 899,896 | 763.2% | $10.35M | Added |
| CLYM | CLIMB BIO INC | $10.73M | 0.49% | 822,649 | 224,987 | 37.6% | $2.93M | Added |
| XBI | SPDR SERIES TRUST Put | $10.67M | 0.49% | 67,400 | 52,400 | 349.3% | $8.29M | Added |
| HLXC | HELIX ACQUISITION CORP III | $10.60M | 0.49% | 1,000,000 | 0 | 0.0% | — | Unchanged |
| ZURA | ZURA BIO LTD | $10.38M | 0.48% | 1,759,295 | 1,128,892 | 179.1% | $6.66M | Added |
| OKUR | ONKURE THERAPEUTICS INC | $10.21M | 0.47% | 2,238,684 | -196,257 | -8.1% | -$894,932 | Reduced |
| MAZE | MAZE THERAPEUTICS INC | $10.12M | 0.46% | 339,276 | 289,181 | 577.3% | $8.63M | Added |
| XENE | XENON PHARMACEUTICALS INC | $10.05M | 0.46% | 166,550 | -62,349 | -27.2% | -$3.76M | Reduced |
| — | TEVA PHARMACEUTICAL INDS LTD | $9.41M | 0.43% | 277,848 | 9,457 | 3.5% | $320,403 | Added |
| URGN | UROGEN PHARMA LTD | $9.29M | 0.43% | 252,395 | -143,064 | -36.2% | -$5.26M | Reduced |
| FTH | FAETH THERAPEUTICS INC | $9.03M | 0.41% | 361,010 | 361,010 | — | $9.03M | New |
| AMLX | AMYLYX PHARMACEUTICALS INC | $8.88M | 0.41% | 494,378 | -506,226 | -50.6% | -$9.09M | Reduced |
| DBVT | DBV TECHNOLOGIES S A | $8.66M | 0.40% | 528,295 | -484,571 | -47.8% | -$7.95M | Reduced |
| SVRA | SAVARA INC | $8.64M | 0.40% | 1,403,409 | -61,126 | -4.2% | -$376,536 | Reduced |
| PCVX | VAXCYTE INC | $8.49M | 0.39% | 146,034 | -113,103 | -43.6% | -$6.57M | Reduced |
| CGON | CG ONCOLOGY INC | $8.43M | 0.39% | 118,664 | -67,035 | -36.1% | -$4.76M | Reduced |
| MLYS | MINERALYS THERAPEUTICS INC | $8.06M | 0.37% | 298,886 | 144,200 | 93.2% | $3.89M | Added |
| ASND | ASCENDIS PHARMA A/S | $7.63M | 0.35% | 28,604 | 3,590 | 14.4% | $957,525 | Added |
| — | AMANAT ACQUISITION CORP | $7.62M | 0.35% | 750,000 | 750,000 | — | — | First reported |
| NRIX | NURIX THERAPEUTICS INC | $7.60M | 0.35% | 313,236 | 257,166 | 458.7% | $6.24M | Added |
| BHVN | BIOHAVEN LTD | $7.47M | 0.34% | 501,687 | 456,910 | 1,020.4% | $6.80M | Added |
| PRME | PRIME MEDICINE INC | $7.37M | 0.34% | 1,997,552 | 24,270 | 1.2% | $89,556 | Added |
| — | PERCEPTIVE CAP SOLUTIONS COR | $7.34M | 0.34% | 674,695 | 175,114 | 35.1% | $1.91M | Added |
| IRD | OPUS GENETICS INC | $7.33M | 0.34% | 1,783,781 | -65,223 | -3.5% | -$268,067 | Reduced |
| LXEO | LEXEO THERAPEUTICS INC | $7.29M | 0.33% | 1,565,950 | 98,600 | 6.7% | $458,983 | Added |
| DMRA | DAMORA THERAPEUTICS INC | $7.28M | 0.33% | 280,000 | 1,000 | 0.4% | $26,010 | Added |
| REPL | REPLIMUNE GROUP INC | $7.26M | 0.33% | 655,784 | -927,203 | -58.6% | -$10.26M | Reduced |
| — | LEONABIO INC | $7.14M | 0.33% | 777,100 | 49,619 | 6.8% | $455,999 | Added |
| KRRO | KORRO BIO INC | $7.12M | 0.33% | 540,054 | 0 | 0.0% | — | Unchanged |
| — | RESEARCH ALLIANCE CORP III | $6.96M | 0.32% | 650,000 | 650,000 | — | — | First reported |
| IFRX | INFLARX NV | $6.72M | 0.31% | 3,000,000 | 2,841,729 | 1,795.5% | $6.37M | Added |
| RLAY | RELAY THERAPEUTICS INC | $6.70M | 0.31% | 358,333 | 358,333 | — | $6.70M | New |
| JANX | JANUX THERAPEUTICS INC | $6.46M | 0.30% | 420,881 | 122,335 | 41.0% | $1.88M | Added |
| — | PLIANT THERAPEUTICS INC | $6.28M | 0.29% | 5,509,724 | 2,924,598 | 113.1% | $3.33M | Added |
| WHWK | WHITEHAWK THERAPEUTICS INC | $6.14M | 0.28% | 1,341,394 | 1,212,891 | 943.9% | $5.56M | Added |
| KRYS | KRYSTAL BIOTECH INC | $6.10M | 0.28% | 16,420 | -3,594 | -18.0% | -$1.34M | Reduced |
| ABUS | ARBUTUS BIOPHARMA CORP | $6.09M | 0.28% | 1,268,147 | -1,865,028 | -59.5% | -$8.95M | Reduced |
| PFE | PFIZER INC | $6.08M | 0.28% | 252,400 | 175,000 | 226.1% | $4.21M | Added |
| BHF | BRIGHTHOUSE FINL INC | $6.05M | 0.28% | 95,523 | 0 | 0.0% | — | Unchanged |
| ABVX | ABIVAX SA Call | $5.92M | 0.27% | 44,400 | 400 | 0.9% | $53,304 | Added |
| EWTX | EDGEWISE THERAPEUTICS INC | $5.82M | 0.27% | 143,199 | 52,600 | 58.1% | $2.14M | Added |
| ALEC | ALECTOR INC | $5.80M | 0.27% | 2,883,583 | 1,833,583 | 174.6% | $3.69M | Added |
| FULC | FULCRUM THERAPEUTICS INC | $5.73M | 0.26% | 1,565,029 | 1,434,469 | 1,098.7% | $5.25M | Added |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $5.69M | 0.26% | 69,800 | -500 | -0.7% | -$40,755 | Reduced |
| — | ACUMEN PHARMACEUTICALS INC | $5.64M | 0.26% | 2,111,334 | -45,000 | -2.1% | -$120,150 | Reduced |
| — | OAKTREE ACQUISITION CORP III | $5.60M | 0.26% | 516,482 | 0 | 0.0% | — | Unchanged |
| GMED | GLOBUS MED INC | $5.54M | 0.25% | 70,100 | 50,000 | 248.8% | $3.95M | Added |
| GLUE | MONTE ROSA THERAPEUTICS INC | $5.25M | 0.24% | 216,752 | 1,000 | 0.5% | $24,200 | Added |
| DGAC/U | DISCIPLINED GROWTH | $5.02M | 0.23% | 500,000 | 500,000 | — | — | First reported |
| — | BHAV ACQUISITION CORP | $5.00M | 0.23% | 495,000 | 0 | 0.0% | — | Unchanged |
| BBIO | BRIDGEBIO PHARMA INC | $5.00M | 0.23% | 30,000 | 0 | 0.0% | — | Unchanged |
| BBIO | BRIDGEBIO PHARMA INC | $4.94M | 0.23% | 45,000 | 0 | 0.0% | — | Unchanged |
| DHR | DANAHER CORP DEL | $4.94M | 0.23% | 25,932 | -5,000 | -16.2% | -$952,400 | Reduced |
| — | BOUNDLESS BIO INC | $4.92M | 0.23% | 1,968,216 | 1,968,216 | — | $4.92M | New |